Skip to main content
. 2022 Dec 29;7(12):e010294. doi: 10.1136/bmjgh-2022-010294

Figure 3.

Figure 3

Prevalence of death or moderate to severe neurodevelopmental disability associated with grades II–III intrapartum-related neonatal encephalopathy in (A) conventional care group with follow-up 1 to <2 years, (B) conventional care group with follow-up ≥2 years, (c) intervention group with follow-up 1 to <2 years, (D) intervention group with follow-up ≥2 years. Prevalence of 1.0=100% adverse outcome. EPO, erythropoietin; TH, therapeutic hypothermia.